Page 23 - PCC10

Clinical trials with hPSC-derived cells
hiPSC
ocular surface disease 3%
spin cord injury 6%
Parkinson's disease 10%
cardiac disease 3%
GVHD 3%
T1 diabetes 10%
DISEASES
USA 32%
UK 13%
Brazil 3%
Japan 10%
retinopathies 65%
COUNTRY
Australia 7%
hESC 84%
China 23%
France 3%
Israel 3%
Korea 6%
PCC Stem Cells - ESHRE BCN 2018
anavei@dexeus.com aveiga@cmrb.eu
Page 17 of 135
PRECONGRESS COURSE 10 I BARCELONA, SPAIN – 1 JULY 2018 23